Skip to main content

Table 1 Baseline characteristics for the 23 patients

From: Analysis of differences between 99mTc-MAA SPECT- and 90Y-microsphere PET-based dosimetry for hepatocellular carcinoma selective internal radiation therapy

Clinical variable Value
Age (years) 63 ± 9
Sex (n)
 Male 21
 Female 2
Child-Pugh class* (n)
 A5 19
 A6 2
 B7 1
BCLC stage (n)
 B 2
 C 21
Prior local therapy** (n)
 Yes 6
 No 17
Tumor morphology (n)
 Infiltrative 15
 Nodular 8
Portal vein thrombosis (n)
 Yes 20
 No 3
Total tumor volume (mL)***
 Mean ± SD 437 ± 344
 Median [range] 353 [58–1250]
Liver tumor involvement (n)
 < 25% 15
 25–50% 8
Treatment (n + 1)
 Whole liver 1
 Lobar 17
 Sectorial 4
 Segmental 2
  1. WHO World Health Organization, BCLC Barcelona Clinic Liver Cancer
  2. *One patient was non-cirrhotic
  3. **Prior local therapies include chemoembolization and radiofrequency ablation
  4. ***Number of lesions was 1 for all treatments except one treatment that concerned 2 lesions